AVONEX is a once-a-week injectable treatment for relapsing multiple sclerosis (MS). It has been prescribed to over 590,000 people worldwide since its approval in 1996. Today it is the #1 prescribed interferon for relapsing MS.†
†This information is an estimate derived from the use of information under license from the following IQVIA information service: IQVIA NPA® NBRx monthly data for the period March 2015–February 2021.
Download a guide to help start a conversation with your healthcare provider about your relapsing MS treatment
If you’re considering AVONEX, get a head start on the process by taking this form to your next visit. It includes step-by-step instructions for you and your healthcare provider